Mikayla L . Spangler, PharmD, BCPS

Associate Professor

Contact

School of Pharmacy and Health Professions
Pharmacy
Pharmacy Faculty
Pharmacy Practice
Faculty - Pharmacy, OT, PT
HLSB - Hixson Lied Science Building - 179

Mikayla L . Spangler, PharmD, BCPS

Associate Professor

Department

Pharmacy Practice

Position

Associate Professor

Books

  • Saxena S, Spangler M, Klug LK. Uveitis. In Domino FJ (Ed.), The 5-Minute Clinical Consult 2017, 25th edition.  Philadelphia: Lippincott Williams & Wilkins. 2017. 2017
  • McGraw-Hill
    Spangler M, Phillips BB. Chronic Anticoagulation. In: Schwinghammer TL, Koehler JM, Borchert JS, Park S, Slain DS, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 10th ed. New York: McGraw-Hill, 2017.   2017
  • Lippincott Williams & Wilkins
    Saxena S, Spangler M, Klug LK. Uveitis. In Domino FJ (Ed.), The 5-Minute Clinical Consult 2016, 24th edition. Philadelphia. 2016. 2016
  • Lippincott Williams & Wilkins
    Spangler ML, Knezevich EL. General Assessment and Vital Signs. In Jones RM, Rospond RM, eds. Patient Assessment in Pharmacy Practice. 3rd ed. Philadelphia. 2015. 2015
  • Lippincott Williams & Wilkins
    Spangler ML, Knezevich EL. Principles and Methods of the Basic Physical Examination. In Jones RM, Rospond RM, eds. Patient Assessment in Pharmacy Practice. 3rd ed. Philadelphia. 2015. 2015
  • Lippincott Williams & Wilkins
    Spangler ML, Knezevich EL. Health and Medication History. In Jones RM, Rospond RM, eds. Patient Assessment in Pharmacy Practice. 3rd ed. Philadelphia. 2015. 2015
  • Lippincott Williams & Wilkins
    Knezevich EL, Spangler ML. Nutritional Assessment. In Jones RM, Rospond RM, eds. Patient Assessment in Pharmacy Practice. 3rd ed. Philadelphia. 2015. 2015
  • Lippincott Williams & Wilkins
    Saxena S, Spangler M, Klug LK. 2014. Uveitis. In Domino FJ (Ed.), The 5-Minute Clinical Consult 2015, 23rd edition. Philadelphia, p. 1252-1253 2015
  • Lippincott Williams & Wilkins
    Saxena S, Spangler M. Breast mass. In: Paulman PM, Paulman AA, Harrison JD, Nasir LS and Jarzynka KJ, eds. Taylor’s Differential Diagnosis Manual 2013, Philadelphia, p. 249-250 2014
  • McGraw-Hill
    Spangler M, Phillips BB. Chronic Anticoagulation. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 9th ed. New York 2014
  • Lippincott Williams & Wilkins
    Saxena S, Spangler M, Viereck LK. Uveitis. 2013. In Domino F (Ed.), The 5-Minute Clinical Consult 2014, 22nd edition. Philadelphia, p. 1296-1297 2014
  • Lippincott Williams & Wilkins
    Saxena S, Spangler M. Dyspareunia. In: Paulman PM, Paulman AA, Harrison JD, Nasir LS and Jarzynka KJ, eds. Taylor’s Differential Diagnosis Manual 2013, Philadelphia, p. 243-245 2013
  • Lippincott Williams & Wilkins
    Spangler M, Knezevich E. Allergic Rhinitis. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2013 Book 2. Special Populations. Lenexa, KS: American College of Clinical Pharmacy, p. 129-144 2013
  • Lippincott Williams & Wilkins
    Saxena SK, Spangler M. 2012. Uveitis. In: Domino F, et al (Eds). The 5-Minute Clinical Consult 2013, 21st edition. Philadelphia, p. 1378-1379 2012
  • McGraw-Hill
    Spangler M, Phillips BB. Chronic Anticoagulation. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 8th ed. New York 2011
  • Lippincott Williams & Wilkins
    Saxena SK, Spangler M. 2011. Uveitis. In: Domino F, et al (Eds). The 5-Minute Clinical Consult 2012, 20th edition. Philadelphia, p. 1386-1387 2011
  • Spangler M, Phillips BB. Chronic Anticoagulation. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 7th ed. New York: McGraw-Hill, 2008.
  • Saxena SK, Spangler M. 2011. Uveitis. In: Domino F, et al (Eds). The 5-Minute Clinical Consult 2012, 20th edition. Philadelphia: Lippincott Williams & Wilkins. p1386-1387
  • Spangler M, Phillips BB. Chronic Anticoagulation. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 8th ed. New York: McGraw-Hill, 2011.
  • Saxena SK, Spangler M. 2012. Uveitis. In: Domino F, et al (Eds). The 5-Minute Clinical Consult 2013, 21st edition. Philadelphia: Lippincott Williams & Wilkins. p1378-1379.
  • Saxena S, Spangler M, Viereck LK. Uveitis. 2013. In Domino F (Ed.), The 5-Minute Clinical Consult 2014, 22nd edition. Philadelphia: Lippincott Williams & Wilkins. p1296-1297.
  • Spangler M, Knezevich E. Allergic Rhinitis. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2013 Book 2. Special Populations. Lenexa, KS: American College of Clinical Pharmacy, 2013:129-144.
  • Saxena S, Spangler M. Dyspareunia. In: Paulman PM, Paulman AA, Harrison JD, Nasir LS and Jarzynka KJ, eds. Taylor’s Differential Diagnosis Manual 2013, Philadelphia: Lippincott Williams & Wilkins, 2013:243-245.
  • Saxena S, Spangler M. Breast mass. In: Paulman PM, Paulman AA, Harrison JD, Nasir LS and Jarzynka KJ, eds. Taylor’s Differential Diagnosis Manual 2013, Philadelphia: Lippincott Williams & Wilkins, 2013:249-250.
  • Spangler M, Phillips BB. Chronic Anticoagulation. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 9th ed. New York: McGraw-Hill, 2014
  • Saxena S, Spangler M, Klug LK. 2014. Uveitis. In Domino FJ (Ed.), The 5-Minute Clinical Consult 2015, 23rd edition. Philadelphia: Lippincott Williams & Wilkins. 2015
  • Saxena S, Spangler M, Klug LK. Uveitis. In Domino FJ (Ed.), The 5-Minute Clinical Consult 2016, 24th edition. Philadelphia: Lippincott Williams & Wilkins. 2016.
  • Knezevich EL, Spangler ML. Nutritional Assessment. In Jones RM (Ed.). Patient Assessment in Pharmacy Practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins. 2015.
  • Spangler ML, Knezevich EL. Health and Medication History. In Jones RM (Ed.). Patient Assessment in Pharmacy Practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins. 2015
  • Spangler ML, Knezevich EL. Principles and Methods of the Basic Physical Examination. In Jones RM (Ed.). Patient Assessment in Pharmacy Practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins. 2015.
  • Spangler ML, Knezevich EL. General Assessment and Vital Signs. In Jones RM (Ed.). Patient Assessment in Pharmacy Practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins. 2015.

Articles

  • Am J Pharmaceutical Education
    Dull RB, Spangler ML, Knezevich EL, Lau BM. Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients with Type 2 Diabetes Mellitus Receiving Oral Therapy. J Pharm Pract 2017; doi: 10.1177/0897190017748049. 2017
  • US Pharmacist
    Schleisman A, Spangler M, Knezevich E. Treatment of Parkinson’s Disease Psychosis. US Pharm 2016;41(11):HS20-HS26. 2016
  • US Pharmacist
    Schleisman A, Spangler M, Knezevich E.  Treatment of Parkinson’s Disease Psychosis.  US Pharm 2016.
    41(11), p. HS20-HS26 2016
  • American Journal of Pharmaceutical Education
    Teply R, Spangler M, Klug L, Tilleman J, Coover K.  Impact of Instruction and Feedback on Reflective Responses during an Ambulatory Care Advanced Pharmacy Practice Experience. 
    80 (5) Article 81, p. 1-7 2016
  • AJHP
    Teply R, Spangler M, Klug L, Tilleman J, Coover K. Impact of Instruction and Feedback on Reflective Responses during an Ambulatory Care Advanced Pharmacy Practice Experience. AJPE 2016;80(5):Article 81. 2016
  • Saxena SK, Spangler ML, Klug LK, Sharma SK. Multiple Sclerosis: A Family Practice Perspective. J Integrative Med Ther 2014;1(1) Available at: http://www.avensonline.org/wp-content/uploads/JIMT-2378-1343-01-0002.pdf 2014
  • Journal of Integrated Medicine and Therapy
    Saxena SK, Spangler ML, Klug LK, Sharma SK. Multiple Sclerosis: A Family Practice Perspective. Available at: http://www.avensonline.org/medical/journal-of-integrative-medicine-therapy/articles-in-press-28/
    1(1) 2014
  • jucm
    Saxena SK, Spangler M, Mikkilineni A. Schamberg’s Disease. JUCM 2013;8:23-24. 2013
  • American Journal of Health-System Pharmacy
    Khandalavala B, Spangler M. Weight loss of 172 pounds with topiramate in a patient with migraine headaches. Am J Health Syst Pharm 2012;69:367-368. 2013
  • Spangler M, Hawley H, Barnes N, Saxena S. A review of asthma guidelines and pharmacological options for asthma treatment with a focus on exercise-induced bronchoconstriction. Phys Sportsmed 2013;41:50-57 2013
  • The Physician and Sportsmedicine
    Spangler M, Hawley H, Barnes N, Saxena S. A review of asthma guidelines and pharmacological options for asthma treatment with a focus on exercise-induced bronchoconstriction. Phys Sportsmed 2013;41:50-57. 2013
  • Journal of Urgent Care Medicine
    Sethi I, Sethi JS, Spangler M, Saxena S. Erythema Infectiosum.
    8, p. 22-23 2013
  • Journal of Urgent Care Medicine
    Saxena SK, Spangler M, Mikkilineni A. Schamberg’s Disease.
    8, p. 23-24 2013
  • Knezevich E, Spangler M. Impact of Psychotropic Medications on Glycemic Control. On the Cutting Edge
    34, p. 13-17 2013
  • Journal of Urgent Care Medicine
    Saxena SK, Spangler M. Perichondritis.
    8, p. 19-21 2013
  • Journal of Urgent Care Medicine
    Saxena S, Spangler M, Sharma SK. Acute low back pain.
    7 , p. 9-16 2013
  • The Physician and Sportsmedicine
    Spangler M, Hawley H, Barnes N, Saxena S. A review of asthma guidelines and pharmacological options for asthma treatment with a focus on exercise-induced bronchoconstriction.
    41, p. 50-57 2013
  • Cornhusker Family Physician
    Hillyard T, Spangler M, Saxena SK. Iliotibial (IT) Band Syndrome: A Primary Care Perspective.
    58, p. 54-55 2013
  • American Journal of Health-System Pharmacy
    Khandalavala, Birgit, Spangler, Mikayla Weight loss of 172 lb with topiramate in a patient with migraine headaches
    69, p. 367-368 2012
  • Cornhusker Family Physician
    Hoang A, Guck T, Spangler M, Saxena S. Evaluation and treatment of needle phobia: a case report.
    58, p. 16-18 2012
  • Cornhusker Family Physician
    Cusack K, Spangler M, Saxena SK. Granuloma annulare: a reflection of systemic disease.
    58, p. 52-53 2012
  • Annals of Pharmacotherapy
    Traut J, MacDonald E, Saxena SK, Spangler M. Montelukast for symptom control of interstitial cystitis. Ann Pharmacother 2011;45:e49. 2011
  • US Pharmacist
    Knezevich EL, Knezevich JT, Spangler ML. Benign prostatic hyperplasia and the medication management of associated lower urinary tract symptoms. US Pharm 2011;36:20-24. 2011
  • American Journal of Health-System Pharmacy
    Spangler, Mikayla, Phillips, Beth B., Ross, Mary B., Moores, Kevin G. Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures
    68, p. 309-318 2011
  • Consultant
    Saxena, Shailendra, K., Dentlinger, Renee, Siedlik, Emily, Spangler, Mikayla Occupational Prepatellar Bursitis
    51, p. 51-51 2011
  • Clinical Advisor for Nurse Practitioners
    Willer, Brittany, L., Siddiqui, Najmul, Saxena, Shailendra, Spangler, Mikayla Clinical Challenge. Neck rash coupled with refractory neuropathic pain
    14, p. 93-98 2011
  • Annals of Pharmacotherapy
    Traut J, MacDonald E, Saxena SK, Spangler M. Montelukast for symptom control of interstitial cystitis.
    45, p. e49 2011
  • US Pharmacist
    Knezevich EL, Knezevich JT, Spangler ML. Benign prostatic hyperplasia and the medication management of associated lower urinary tract symptoms.
    36, p. 20-24 2011
  • Cornhusker Family Physician
    Krull A, Sharaf S, Spangler M, Khandalavala B. Open and shut: a review of pharmacology for insomnia and narcolepsy.
    65, p. 22-25 2011
  • Cornhusker Family Physician
    Saxena SK, Dentlinger R, Siedlik E, Spangler M. Occupational prepatellar bursitis. Consultant
    51, p. 21-23 2011
  • jucm
    Langerman E, Czerniak C, Spangler M, Saxena SK. Case report: Stye or chalazion? JUCM, December 2010. Web Exclusive. Available at: http://jucm.com/read/casereport.php?casereport=21 2010
  • Consultant (00107069)
    Nash, D., Spangler, M., Saxena, S. What's your diagnosis?
    50, p. 481-482 2010
  • Clinical Therapeutics
    Spangler, Mikayla L., Saxena, Shailendra Warfarin and bosentan interaction in a patient with pulmonary hypertension secondary to bilateral pulmonary emboli
    32, p. 53-56 2010
  • Medical Devices: Evidence and Research
    Sexson, E. L., Spangler, M. L., Foral, P. A., Davis, Estella M. An Evaluation of Pre-filled Insulin Pens: a focus on the Next Generation FlexPen®
    3, p. 41-50 2010
  • AWP Newsletter
    Spangler M. Review of medications for the treatment of diabetes mellitus. The Spectrum. Pharmacy Department Newsletter, UIHC, Iowa City, IA September 2005.
  • Journal of Pharmacy and Pharmacology
    Spangler M. Choosing a residency program- a conversation with current Iowa residents. The Journal of the Iowa Pharmacy Association. Iowa Pharmacy Association, Des Moines, IA January/February, 2006
  • Cornhusker Family Physician
    Herrmann J, McCullough B, Spangler M, Saxena SK. Testosterone replacement therapy for erectile dysfunction. Cornhusker Family Physician 2008;54:20-21.
  • Cornhusker Family Physician
    Childress K, Spangler M, Saxena SK. Pharmacological management of Alzheimer’s disease. Cornhusker Family Physician 2009;54:28-29.
  • Clin Ther
    Spangler M, Saxena SK. Warfarin and bosentan interaction in a patient with pulmonary hypertension secondary to bilateral pulmonary emboli. Clin Ther 2010;32:53-6.
  • Samindla D, Braig B, Spangler M, Saxena SK. Here comes the sunburn: an update. JUCM 2010;4:22-30.
  • Medical Devices: Evidence and Research
    Davis E, Sexson E, Spangler M, Foral P. An evaluation of pre-filled insulin pens: a focus on the Next Generation FlexPen®. Medical Devices: Evidence and Research 2010;3:41-50.
  • Saxena SK, Rafiq N, George L, Olsen C, Spangler M. Promethazine induced tissue necrosis. JUCM 2010;4:21-22, 26.
  • Currents in Pharmacy Teaching and Learning
    Packard K, Sexson E, Spangler M. A novel cardiovascular risk screening and health promotion service learning course. Currents in Pharmacy Teaching and Learning 2010;2(4):228-37.
  • AJHP
    Spangler M, Phillips BB, Ross M, Moores K. Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures. AJHP 2011;68:309-318.
  • jucm
    Saxena S, Spangler M, Sharma SK. Acute low back pain. JUCM 2013;7:9-16.
  • Saxena SK, Spangler M. Perichondritis. JUCM 2013;8:19-21.
  • jucm
    Sethi I, Sethi JS, Spangler M, Saxena S. Erythema Infectiosum. JUCM 2013;8:22-23.
  • On the Cutting Edge Diabetes
    Knezevich E, Spangler M. Impact of Psychotropic Medications on Glycemic Control. On the Cutting Edge 2013;34:13-17.

Presentations

  • Spangler M. Clinical Pearls: OTC Medications. Invited presentation to pharmacists at the 2017 Midwest Pharmacy Expo, Des Moines, IA. February 18, 2017. 2017
  • Spangler M. Clinical Pearls: OTC Medications. Invited presentation to pharmacists at the 2017 Midwest Pharmacy Expo, Des Moines, IA. February 18, 2017. 2017
  • Neighbors K, Worth B, Knezevich K, Spangler M. For the greater good: pharmacy student interventions to optimize therapy and cost savings at Healing Gift Free Clinic. American Society of Healthsystems Pharmacists 2016 Annual Meeting, Las Vegas, NV. 2016
  • Spangler M. Ambulatory Care Pharmacy Practice. Invited presentation at Creighton University School of Pharmacy and Health Professions for the Pharmacy Explorers Program for high school students, Omaha, NE. April 25, 2015. 2015
  • Spangler M. Alphabet Soup: Use of SGLT-2, DPP-4, and GLP-1s for Diabetes. Invited presentation to pharmacists at the 2015 Midwest Pharmacy Expo, Des Moines, IA. February 14, 2015. 2015
  • Spangler M, Klug L. Ambulatory Care Pharmacy Practice. Invited presentation at Creighton University School of Pharmacy and Health Professions for the HyVee Explorers Program for high school students, Omaha, NE. July 11, 2014. 2014
  • Spangler M. Hypertension and hyperlipidemia guideline update. Invited presentation at Creighton University School of Pharmacy and Health Professions for third year pharmacy students, Omaha, NE. February 25, 2014. 2014
  • Spangler M. New Guidelines for Treatment of Hyperlipidemia and Hypertension. Invited presentation at the Creighton University Family Medicine Residency Friday Conference, Omaha, NE. January 17, 2014. 2014
  • Spangler M. Drugs During Pregnancy: Risk Assessment and Medication Recommendations. Invited presentation at the Creighton University Family Medicine Residency Friday Conference, Omaha, NE. August 23, 2013. 2013
  • Spangler M. Medications to Improve Incretin Function. Invited presentation at Alegent Creighton Clinic- Lakeside Family Medicine Providers Meeting, Omaha, NE. July 19, 2013. 2013
  • Spangler M. Medications to Improve Incretin Function. Invited presentation at Alegent Creighton Clinic- Lakeside Family Medicine Providers Meeting, Omaha, NE. July 19, 2013. 2013
  • Spangler M. Ambulatory Care Pharmacy Practice. Invited presentation at Metro Omaha Coders Association Spring Workshop, Omaha, NE. May 17, 2013. 2013
  • Spangler M. Ambulatory Care Pharmacy Practice. Invited presentation at Metro Omaha Coders Association Spring Workshop, Omaha, NE. May 17, 2013. 2013
  • Spangler M. Hypertension and Antihypertensive Medication Review. Invited presentation at Creighton University School of Pharmacy and Health Professions NAPLEX review course to fourth year pharmacy students, Omaha, NE. May 2, 2013. 2013
  • Spangler M. Hypertension and Antihypertensive Medication Review. Invited presentation at Creighton University School of Pharmacy and Health Professions NAPLEX review course to fourth year pharmacy students, Omaha, NE. May 2, 2013. 2013
  • Malcom H, Teply R, Spangler M, Klug L. Depression and medication taking behavior. St. Albert's Day/University Research Day, Creighton University. Omaha, NE, March 26, 2013. 2013
  • Teply R, Spangler M, Klug L, Tilleman J, Coover K. Evaluation of the impact of instruction and feedback on reflective responses completed by 4th year pharmacy students on their ambulatory care advanced pharmacy practice experience. American College of Clinical Pharmacy 2013 Annual Meeting, Albuquerque, NM. Abstract: Pharmacother 2013; 33 (10): e197. 2013
  • Spangler M. Hypertension and Antihypertensive Medication Review. Invited presentation at Creighton University School of Pharmacy and Health Professions NAPLEX review course to fourth year pharmacy students, Omaha, NE. May 3, 2012. 2012
  • Spangler M. Hypertension and Antihypertensive Medication Review. Invited presentation at Creighton University School of Pharmacy and Health Professions NAPLEX review course to fourth year pharmacy students, Omaha, NE. May 3, 2012. 2012
  • Spangler M. Weight Loss in Diabetes- It IS Possible. Invited presentation to physicians, nurse practitioners, physician assistants, and dietitians at the 4th annual Obesity 360 Conference, Omaha, NE. March 18, 2011. 2011
  • Spangler M. Weight Loss in Diabetes- It IS Possible. Invited presentation to physicians, nurse practitioners, physician assistants, and dietitians at the 4th annual Obesity 360° Conference, Omaha, NE. March 18, 2011. 2011
  • Ahmad R, Spangler M, Saxena S. The effect of continuous positive airway pressure treatment for obstructive sleep apnea/hypopnea on type 2 diabetes, hypertension and an abnormal lipid profile. Poster presentation on research in progress at the 2011 North American Primary Care Research Group Annual Meeting, 2011. Banff, Alberta, Canada. Abstract: Family Medicine 2012; 44(Suppl 1). Available at: http://www.stfm.org/fmsup/napcrg/fmconferencesupplement.cfm?confid=137 2011
  • Spangler M. Ambulatory Care Pharmacy. Invited presentation at Creighton University's chapter of the American Pharmacists Association-Academy of Student Pharmacists meeting to pharmacy students, Omaha, NE. October 13, 2010. 2010
  • Spangler M, Knezevich E. Motivational Interviewing. Invited presentation at Creighton University School of Pharmacy and Health Professions Faculty Development Session to occupational therapy, physical therapy and pharmacy faculty, Omaha, NE. July 13, 2010. 2010
  • Spangler M. Finally (or just about) Exciting New Weight Loss Drugs. Invited presentation to physicians, nurse practitioners, physician assistants, and dietitians at the 3rd annual Obesity 360° Conference, Omaha, NE. March 19, 2010. 2010
  • Spangler M. The New Meds on the Block. Invited presentation at the Creighton University Family Medicine Residency Friday Conference, Omaha, NE. October 9, 2009. 2009
  • Spangler M. The New Meds on the Block. Invited presentation at the 2009 Primary Care Update to primary care physicians, Okoboji, IA. May 22, 2009 2009
  • Spangler M. Practical Pharmacology- What to Use and What Not to Use. Invited presentation to physicians, nurse practitioners, physician assistants, and dietitians at the 2nd annual Obesity 360° Conference, Omaha, NE. March 20, 2009. 2009
  • Spangler M. Practical Pharmacology- What to Use and What Not to Use. Invited presentation to physicians, nurse practitioners, physician assistants, and dietitians at the 1st annual Obesity 360° Conference, Omaha, NE. March 7, 2008. 2008
  • Spangler M. Evaluation of Diabetes Outcomes and Management in a Multidisciplinary Diabetes Clinic Compared to Usual Care. Presented at the 33rd Annual Midwest Pharmacy Residents Conference to pharmacy residents and clinical pharmacists, Omaha, NE. April 30, 2007. 2007
  • Spangler M. The Calcium Controversy: Does it really reduce fracture risk? Invited presentation at Geriatric Grand Rounds to physicians, nurse practitioners and pharmacists, UIHC, Iowa City, IA. February 28, 2007. 2007
  • Spangler M. Current Controversies in the Treatment and Prevention of Osteoporosis. Invited presentation at the Johnson County Pharmacy Association Meeting to pharmacists, Iowa City, IA. January 23, 2007. 2007
  • Spangler M, Horner K, Hemerson P, Bramble A, Phillips BB, Newkirk E, McDanel D. Use of a bleeding risk assessment tool in an anticoagulation service. The 8th Annual Research Achievement Symposium and Poster Session 2007, University of Iowa College of Pharmacy, Iowa City, IA. 2007
  • Spangler M. Evaluation of Diabetes Outcomes and Management in a Multidisciplinary Diabetes Clinic Compared to Usual Care. Presented at the 32nd Annual Midwest Pharmacy Residents Conference to pharmacy residents and clinical pharmacists, Omaha, NE. April 29, 2006. 2006
  • Spangler M. Bridging with Low Molecular Weight Heparin. Presented to clinical pharmacists and pharmacy residents, UIHC, Iowa City, IA. October 27, 2005. 2005
  • Spangler M. Anticoagulation in Patients with Prothrombin 20210A Gene Mutation. Presented to clinical pharmacists and pharmacy residents, UIHC, Iowa City, IA. August 18, 2005. 2005
  • Spangler M, Phillips BB, Newkirk E, McDanel D. Evaluation of diabetes outcomes and management in a multidisciplinary diabetes clinic compared to usual care. The 7th Annual Research Achievement Symposium and Poster Session 2006, University of Iowa College of Pharmacy, Iowa City, IA.
  • Spangler M, Sheeley E, Phillips BB, Newkirk E, McDanel D. Evaluation of diabetes outcomes and management in a multidisciplinary diabetes clinic compared to usual care. The 8th Annual Research Achievement Symposium and Poster Session 2007, University of Iowa College of Pharmacy, Iowa City, IA.
  • Rafiq N, Jyoti K, Spangler M, Saxena SK. Pheochromocytoma: a family practice perspective. Nebraska Academy of Family Physicians 61st Annual Scientific Assembly, 2009. Lincoln, NE.
  • Shah D, Agarwal S, Spangler M, Saxena SK. Obstructive sleep apnea: a family practice perspective. Nebraska Academy of Family Physicians 61st Annual Scientific Assembly, 2009. Lincoln, NE
  • Neighbors K, Worth B, Knezevich K, Spangler M. For the greater good: pharmacy student interventions to optimize therapy and cost savings at Healing Gift Free Clinic. American Society of Healthsystems Pharmacists 2016 Annual Meeting, Las Vegas, NV.
  • Elsasser GN, Christensen KR, Spangler M, Clark B, Davis R, Young WW. Facilitating distance student participation on a pharmacy admission committee via web-cam technology. 110th Annual Meeting of the American Association of Colleges of Pharmacy, 2009. Boston, MA.
  • Packard K, Spangler M, Sexson E, Lust WE, Walters R. Impact of a cardiovascular risk screening and health promotion service learning course. 110th Annual Meeting of the American Association of Colleges of Pharmacy, 2009. Boston, MA.
  • Spangler M, Newkirk E, McDanel D, Phillips BB. Evaluation of diabetes outcomes and management in a multidisciplinary diabetes management clinic compared to usual care. American College of Clinical Pharmacy 2007 Annual Meeting, Denver, CO.
  • Spangler M, Phillips BB, Newkirk E, McDanel D. Evaluation of patient outcomes and management in a multidisciplinary diabetes clinic compared to usual care. University HealthSystem Consortium Pharmacy Council Meeting 2006, Anaheim, CA.
  • Spangler M, Phillips BB, Newkirk E, McDanel D. Evaluation of patient outcomes and management in a multidisciplinary diabetes clinic compared to usual care. University HealthSystem Consortium Pharmacy Council Meeting 2005, Las Vegas, NV.

Awards

  • Faculty Excellence in Leadership Award
    Phi Lambda Sigma Alpha Mu Chapter
  • Excellence in Scholarly Activity Award
    Department of Family Medicine Creighton University
  • Educator of the Year
    Creighton University School of Pharmacy Class of 2015

Consulting

  • Services Collaborative Creighton University
    team participant
    • National task force to improve Medicare insured patient outcomes through clinical pharmacy services
    Health Resources and Services Administration Patient Safety and Clinical Pharmacy
    2012 - 2013